Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Forster

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
[18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancerRyohei Sasaki, Ritsuko Komaki, Homer Macapinlac, et al.
Magnetic Resonance Imaging|August 18, 2012
Radiomics: the process and the challengesVirendra Kumar, Yuhua Gu, Satrajit Basu, et al.
The Lancet. Oncology|January 21, 2015
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 studyJeffrey D Bradley, Rebecca Paulus, Ritsuko Komaki, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
[18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancerRyohei Sasaki, Ritsuko Komaki, Homer Macapinlac, et al.
Magnetic Resonance Imaging|August 18, 2012
Radiomics: the process and the challengesVirendra Kumar, Yuhua Gu, Satrajit Basu, et al.
The Lancet. Oncology|January 21, 2015
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 studyJeffrey D Bradley, Rebecca Paulus, Ritsuko Komaki, et al.
Pageof 4